Can Oxytocin Be Used to Treat Postpartum Depressive Symptoms?
Intranasal oxytocin improves mood in postpartum women but has no impact on mood in women with more severe depressive symptoms.
Essential Reads: Lamotrigine (Lamictal) Dosing During Pregnancy
About 60% of women with mood disorders experience premenstrual exacerbation or PME of their mood during the premenstrual phase of their cycle.
Essential Reads – Psychotropic Treatment During Pregnancy: Research Synthesis and Clinical Care Principles
This review article provides clinically relevant data but also helps the reader navigate some of the more controversial issues in the field.
Essential Reads: Cognitive Behavioral Therapy for Insomnia During Pregnancy
Cognitive-behavioral therapy specifically designed for insomnia (CBT-I) is a useful adjunct or alternative to medication for women during pregnancy.
A Novel Collaborative Group Intervention for Mothers with Perinatal Mental Illness and Their Infants
“Together in Mind” is a group intervention for mothers diagnosed with moderate to severe mental illness and their infants.
Sage Therapeutics and Biogen Announce Plans to Submit a New Drug Application for Zuranolone to the FDA in 2022
The FDA will review zuranolone for the treatment of depression in the first half of 2022.
Essential Reads: A Comprehensive Review of Brexanolone for the Treatment of Postpartum Depression
This review discusses the novel neurosteroid antidepressant brexanolone for the treatment of postpartum depression.
Essential Reads: Investigational Treatment of Depressive Disorders With Neuroactive Steroids: Potential Implications for PMDD
Neuroactive steroids, derivatives of allopregnanolone, may be effective for the treatment of premenstrual dysphoric disorder.
Essential Reads: Bright Light Therapy for the Treatment of Depression During Pregnancy, Mixed Findings
In terms of the efficacy of bright light therapy for depression during pregnancy, the jury is still out.
Essential Reads: Medications for Smoking Cessation in Breastfeeding Women
Our information on the use of medications for smoking cessation in nursing mothers is limited.